Maven Capital Partners — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
CALCIVIS develops the CALCIVIS Imaging System, a chairside diagnostic device that provides real-time assessment of enamel demineralization and tooth decay activity to support preventive dentistry.
BiotechDigital HealthHealthtechMedical DevicesEdinburgh, GB
Gregory M. Sheehan(CEO)inJill McGregor(COO)inBruce Vernon(Co-founder & CTO)Peter Anthony Rees(Director)Adam Christie(Co-founder & CEO)James Jonathan Browning(Director)
Co-investorsScottish National Investment BankBritish Business BankScottish EnterpriseScottish Investment Bank
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateInvesting Women Angels+3 more
The Concinnity Company provides a cloud-based process management and automation platform designed to reduce delays and improve efficiency in clinical trials.
Cloud ComputingDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSNashville, US
Heidi Solomon Allen(Secretary)inMichael Alan Lalor(Chief Financial Officer)Nancy Falls(Chief Executive Officer)in
Co-investorsEos AdvisoryOld College CapitalScottish Enterprise
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.